TGF-β2 Reduces Demyelination, Virus Antigen Expression, and Macrophage Recruitment in a Viral Model of Multiple Sclerosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (45)
Deactivation of macrophages by transforming growth factor-β
1988 • 876 citations
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination
1975 • 615 citations
Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.
1990 • 507 citations
Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.
1987 • 466 citations
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
1991 • 400 citations
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
1991 • 385 citations
Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.
1988 • 298 citations
Primary demyelination in Theiler's virus infection. An ultrastructural study.
1975 • 273 citations
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis
1983 • 243 citations
Theiler's Virus-Induced Demyelination: Prevention by Immunosuppression
1976 • 242 citations
Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors.
1995 • 179 citations
Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
1991 • 147 citations
Role of macrophages during Theiler's virus infection
1997 • 130 citations
Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody.
1988 • 128 citations
CD4+and CD8+T Cells Make Discrete Contributions to Demyelination and Neurologic Disease in a Viral Model of Multiple Sclerosis
1998 • 117 citations
Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis.
1994 • 116 citations
Partial suppression of Theiler's virus‐induced demyelination in vivo by administration of monoclonal antibodies to immune‐response gene products (Ia antigens)
1986 • 104 citations
Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system
1993 • 103 citations
T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs.
1993 • 88 citations
Transforming growth factors β1 and β2: cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function
1989 • 84 citations
Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease.
1995 • 76 citations
Gamma interferon is critical for resistance to Theiler's virus-induced demyelination
1995 • 76 citations
Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β2
1993 • 74 citations
Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice
1996 • 68 citations
Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue
1997 • 61 citations
Theiler's virus infection induces a specific cytotoxic T lymphocyte response
1991 • 57 citations
Transforming growth factor-β1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expression
1997 • 55 citations
Inhibition of Theiler's Virus-induced demylination in vivo by tumor necrosis factor alpha
1990 • 53 citations
Theiler's virus replication in brain macrophages cultured in vitro
1992 • 52 citations
Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination
1986 • 50 citations
Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus.
1989 • 43 citations
Transforming growth factor-β inhibits apoptosis induced by β-amyloid peptide fragment 25–35 in cultured neuronal cells
1998 • 43 citations
Erichrome Stain for Myelin on Osmicated Tissue Embedded in Glycol Methacrylate Plastic
1989 • 42 citations
Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation
1990 • 42 citations
Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene
1990 • 39 citations
VP1 and VP2 Capsid Proteins of Theiler's Virus Are Targets of H-2D-Restricted Cytotoxic Lymphocytes in the Central Nervous System of B10 Mice
1995 • 38 citations
Differential generation of class I H‐2D‐ versus H‐2K‐restricted cytotoxicity against a demyelinating virus following central nervous system infection
1997 • 36 citations
Theiler’s Virus Infection of Genetically Susceptible Mice Induces Central Nervous System-Infiltrating CTLs with no Apparent Viral or Major Myelin Antigenic Specificity
1998 • 35 citations
In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence
1997 • 22 citations
Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination.
1991 • 19 citations
Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis.
1998 • 16 citations
Human class I major histocompatibility complex transgene prevents virus‐induced demyelination in susceptible mutant B 10.d2dml mice
1993 • 13 citations
Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis
1998 • 13 citations
Transforming growth factor-beta 1 enhances the generation of allospecific cytotoxic T lymphocytes.
1993 • 13 citations
Antigenic variants are not selected during persistent infection with Theiler's virus
1983 • 7 citations